Joakim Tedroff

3.4k total citations · 1 hit paper
86 papers, 2.5k citations indexed

About

Joakim Tedroff is a scholar working on Cellular and Molecular Neuroscience, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joakim Tedroff has authored 86 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Cellular and Molecular Neuroscience, 50 papers in Neurology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joakim Tedroff's work include Neurological disorders and treatments (39 papers), Neuroscience and Neuropharmacology Research (36 papers) and Parkinson's Disease Mechanisms and Treatments (33 papers). Joakim Tedroff is often cited by papers focused on Neurological disorders and treatments (39 papers), Neuroscience and Neuropharmacology Research (36 papers) and Parkinson's Disease Mechanisms and Treatments (33 papers). Joakim Tedroff collaborates with scholars based in Sweden, United States and Italy. Joakim Tedroff's co-authors include Nicholas Waters, Per Hartvig, Bengt Långström, Arvid Carlsson, Maria Carlsson, Marie K. L. Nilsson, Peter Bjurling, Sten‐Magnus Aquilonius, Richard Torstenson and B. L�ngstr�m and has published in prestigious journals such as Neurology, Annals of Neurology and The Lancet Neurology.

In The Last Decade

Joakim Tedroff

85 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence

2001 527 citations Arvid Carlsson, Nicholas Waters et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Joakim Tedroff	1.5k	948	615	381	354	86	2.5k
Nicholas Waters	2.1k 1.4×	413 0.4×	1.3k 2.1×	555 1.5×	488 1.4×	75	3.1k
Takeharu Kakiuchi	1.4k 0.9×	328 0.3×	980 1.6×	388 1.0×	189 0.5×	110	2.9k
Mikko Kuoppamäki	1.1k 0.7×	784 0.8×	386 0.6×	363 1.0×	528 1.5×	52	2.0k
Roberto Maggio	2.3k 1.6×	471 0.5×	2.4k 4.0×	275 0.7×	385 1.1×	111	4.0k
E. D. Bird	2.0k 1.4×	967 1.0×	1.3k 2.1×	243 0.6×	246 0.7×	23	2.7k
Junchao Tong	1.8k 1.2×	961 1.0×	617 1.0×	339 0.9×	224 0.6×	89	3.0k
Shingo Nishiyama	1.4k 0.9×	249 0.3×	1.1k 1.8×	344 0.9×	205 0.6×	102	3.0k
Marc Marien	1.5k 1.0×	671 0.7×	803 1.3×	343 0.9×	166 0.5×	48	2.6k
C H van Dyck	968 0.6×	307 0.3×	446 0.7×	355 0.9×	636 1.8×	12	2.1k
A. B. Young	2.6k 1.8×	923 1.0×	1.5k 2.4×	521 1.4×	262 0.7×	46	3.5k

Countries citing papers authored by Joakim Tedroff

Since Specialization

Citations

This map shows the geographic impact of Joakim Tedroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joakim Tedroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joakim Tedroff more than expected).

Fields of papers citing papers by Joakim Tedroff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joakim Tedroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joakim Tedroff. The network helps show where Joakim Tedroff may publish in the future.

Co-authorship network of co-authors of Joakim Tedroff

This figure shows the co-authorship network connecting the top 25 collaborators of Joakim Tedroff. A scholar is included among the top collaborators of Joakim Tedroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joakim Tedroff. Joakim Tedroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Antonini, Angelo, Padraig O’Suilleabhain, Fabrizio Stocchi, et al.. (2025). Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial. Movement Disorders Clinical Practice. 12(6). 796–806. 4 indexed citations

Stan, Tiberiu Loredan, Pär Halje, Azat Nasretdinov, et al.. (2025). Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa‐Induced Dyskinesia. European Journal of Neuroscience. 61(5). e70032–e70032.

Waters, Nicholas, Clas Sonesson, Peder Svensson, et al.. (2020). Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics. 374(1). 113–125. 18 indexed citations

Hjorth, Stephan, Nicholas Waters, Nicholas Waters, et al.. (2020). (3S)‐3‐(2,3‐difluorophenyl)‐3‐methoxypyrrolidine (IRL752) —a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent. Journal of Pharmacology and Experimental Therapeutics. 374(3). 404–419. 4 indexed citations

Jacobson, Lena, et al.. (2020). Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway. The Journal of Headache and Pain. 21(1). 99–99. 19 indexed citations

Waters, Nicholas, et al.. (2018). Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington’s Disease. Journal of Huntington s Disease. 7(1). 1–16. 20 indexed citations

Svenningsson, Per, Anders Johansson, Dag Nyholm, et al.. (2018). Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial. npj Parkinson s Disease. 4(1). 35–35. 19 indexed citations

Helldén, Anders, Georgios Panagiotidis, Petter Johansson, et al.. (2012). The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humans. European Journal of Clinical Pharmacology. 68(9). 1281–1286. 3 indexed citations

Dorey, J, Joakim Tedroff, Ferdinando Squitieri, et al.. (2011). PND38 International Comparison of Huntington Disease (HD) Burden. Value in Health. 14(7). A324–A324. 2 indexed citations

10.

Lundin, Anders, Espen Dietrichs, Sara Haghighi, et al.. (2010). Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease. Clinical Neuropharmacology. 33(5). 260–264. 56 indexed citations

11.

Гефверт, О., Leif Lindström, Nicholas Waters, et al.. (2003). Different corticostriatal patterns of L‐DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. Scandinavian Journal of Psychology. 44(3). 289–292. 20 indexed citations

12.

Nilsson, Dag, Hans Lennernäs, Anders Sundin, et al.. (1999). Absorption of l-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography.. European Journal of Pharmaceutical Sciences. 7(3). 185–189. 4 indexed citations

13.

Sonesson, Clas, et al.. (1997). OSU6182 a representative from a unique class of functional modulators of dopaminergic systems. The Society for Neuroscience Abstracts. 23. 531. 3 indexed citations

14.

Hartvig, Per, Richard Torstenson, Clas Sonesson, et al.. (1997). Synthesis of [11C-methyl]-(−)-OSU6162, its regional brain distribution and some pharmacological effects of (−)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography. Nuclear Medicine and Biology. 24(6). 507–511. 13 indexed citations

15.

Tedroff, Joakim. (1997). The Neuroregulatory Properties of L-DOPA. A Review of the Evidence and Potential Role in the Treatment of Parkinson's Disease. Reviews in the Neurosciences. 8(3-4). 195–204. 37 indexed citations

16.

Andrén, Per E., et al.. (1997). (−)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinsonʼs disease. Neuroreport. 8(11). 2567–2570. 23 indexed citations

17.

Tedroff, Joakim, Marie Pedersen, Aquilonius Sm, et al.. (1996). Levodopa‐induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [¹¹C]raclopride displacement and PET. Neurology. 46(5). 1430–1430. 122 indexed citations

18.

Westermark, Kerstin, Joakim Tedroff, Per Hartvig, et al.. (1995). Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers. Movement Disorders. 10(5). 596–603. 33 indexed citations

19.

Hartvig, Per, et al.. (1992). PET STUDIES WITH l-[11C]5-HTP AND l-[11C]DOPA IN BRAINS OF HEALTHY VOLUNTEERS AND PATIENTS WITH MAJOR DEPRESSION. Clinical Neuropharmacology. 15. 235A–236A. 6 indexed citations

20.

Bredberg, Eva, Joakim Tedroff, S.‐M. Aquilonius, & L Paalzow. (1990). Pharmacokinetics and effects of levodopa in advanced Parkinson's disease. European Journal of Clinical Pharmacology. 39(4). 385–389. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact